News & Updates
Filter by Specialty:
Antidepressant exposure in pregnancy not a risk factor for neonatal seizures, epilepsy
In pregnant women, the use of serotonergic antidepressants does not appear to put babies at risk of developing seizures or epilepsy, as reported in a study.
Antidepressant exposure in pregnancy not a risk factor for neonatal seizures, epilepsy
20 May 2022
Relugolix combo improves uterine fibroid symptoms regardless of fibroid location
Combination therapy with relugolix (once daily relugolix 40 mg, estradiol 1 mg, norethindrone acetate 0.5 mg) leads to improvement in heavy menstrual bleeding (HMB) and in other uterine fibroid (UF)-related symptoms independent of the location of the largest fibroid, results of a recent study have shown.
Relugolix combo improves uterine fibroid symptoms regardless of fibroid location
17 May 2022
Pelvic floor dysfunction in women warrants further attention
There appears to be a dearth of evidence on the management of nonrelaxing pelvic floor dysfunction (PFD), a debilitating condition characterized by tension of the pelvic floor muscles that frequently leads to pelvic pain, according to data presented at ACOG 2022.
Pelvic floor dysfunction in women warrants further attention
17 May 2022
ED-dispensed mifepristone plus misoprostol improves access to early pregnancy loss care
Administering mifepristone and misoprostol in the emergency departments (EDs) appears to be effective, increasing the availability of early pregnancy loss medical management services to women during the COVID-19 pandemic in the US, as shown in a study presented at the 2022 American College of Obstetricians and Gynecologists (ACOG) Annual Clinical & Scientific Meeting.